1. 18F-Fluorothymidine PET for Functional Response Assessment Following Radiation Therapy for Extramedullary Hematopoiesis. (September 2021) Authors: Campbell, Belinda A.; Callahan, Jason; Cole-Sinclair, Merrole; MacManus, Michael; Hofman, Michael S. Journal: Clinical nuclear medicine Issue: Volume 46:Number 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Novel Application of [18F]Fluorothymidine-PET ([18F]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy. (November 2019) Authors: Campbell, Belinda A.; Hofman, Michael S.; Prince, H. Miles Journal: Clinical nuclear medicine Issue: Volume 44:Number 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol. (3rd June 2018) Authors: Hofman, Michael S.; Murphy, Declan G.; Williams, Scott G.; Nzenza, Tatenda; Herschtal, Alan; Lourenco, Richard De Abreu; Bailey, Dale L.; Budd, Ray; Hicks, Rodney J.; Francis, Roslyn J.; Lawrentschuk, Nathan Journal: BJU international Issue: Volume 122:Number 5(2018) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging. Issue 11 (10th October 2013) Authors: Jackson, Price A.; Beauregard, Jean‐Mathieu; Hofman, Michael S.; Kron, Tomas; Hogg, Annette; Hicks, Rodney J. Journal: Medical physics Issue: Volume 40:Issue 11(2013) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Are dynamic or fixed FDG‐PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B‐cell lymphoma undergoing autologous haematopoietic stem cell transplantation?. (4th April 2023) Authors: Campbell, Belinda A.; Brown, Rachel; Lambertini, Alessandro; Hofman, Michael S.; Bressel, Mathias; Seymour, John F.; Wirth, Andrew; MacManus, Michael; Dickinson, Michael Journal: British journal of haematology Issue: Volume 201:Number 3(2023) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single‐centre study. Issue 4 (16th February 2020) Authors: Young, Rebekah; Snow, Hayden; Hendry, Shona; Mitchell, Catherine; Slavin, John; Schlicht, Stephen; Na, Lumine; Hofman, Michael S.; Gyorki, David E. Journal: ANZ journal of surgery Issue: Volume 90:Issue 4(2020) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Detection and localisation of primary prostate cancer using 68gallium prostate‐specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology. (1st July 2020) Authors: Kalapara, Arveen A.; Nzenza, Tatenda; Pan, Henry Y.C.; Ballok, Zita; Ramdave, Shakher; O'Sullivan, Richard; Ryan, Andrew; Cherk, Martin; Hofman, Michael S.; Konety, Badrinath R.; Lawrentschuk, Nathan; Bolton, Damien; Murphy, Declan G.; Grummet, Jeremy P.; Frydenberg, Mark Journal: BJU international Issue: Volume 126:Number 1(2020) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901). (6th July 2021) Authors: Emmett, Louise; Subramaniam, Shalini; Joshua, Anthony M.; Crumbaker, Megan; Martin, Andrew; Zhang, Alison Y.; Rana, Nisha; Langford, Ailsa; Mitchell, Jenna; Yip, Sonia; Francis, Roslyn; Hofman, Michael S.; Sandhu, Shahneen; Azad, Arun; Gedye, Craig; McJannett, Margaret; Stockler, Martin R.; Davis... Journal: BJU international Issue: Volume 128:Number 5(2021) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Estimating lung ventilation directly from 4D CT Hounsfield unit values. Issue 1 (17th December 2015) Authors: Kipritidis, John; Hofman, Michael S.; Siva, Shankar; Callahan, Jason; Le Roux, Pierre‐Yves; Woodruff, Henry C.; Counter, William B.; Keall, Paul J. Journal: Medical physics Issue: Volume 43:Issue 1(2016) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluating the place of 18-fluoro-2-deoxy-d-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma. Issue 10 (October 2013) Authors: Seymour, John F.; Trotman, Judith; Hofman, Michael S. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗